being and becoming in the world
Evidence has repeatedly demonstrated that when marketing is conflated with medical education the consequences can not just be harmful but also undermine the scientific pursuit of objectivity.
This Wednesday, Professor John Krystal, Yale University, has been invited by BAP to give this talk: ‘Linking depression pathophysiology to the mechanism of action of ketamine and “next generation” treatments’ … Continue reading BAP Summer Meeting 2024: Guest Lecture
This BAP educational session is funded by Boehringer Ingelheim. It takes place on Tuesday 23rd July.
This CME session for BAP takes place on Monday. The session is chaired by Dr Sameer Jauhar: BAP provides this summary of the session: Several contributors to this BAP session … Continue reading BAP Summer Meeting: “50 years of hurt?”
This is one of tomorrow’s educational sessions at the BAP Summer Meeting: BAP provide this summary for tomorrows CME meeting: Contributing to this CME meeting: Professor Guy Goodwin is a … Continue reading BAP: Advancing psychopharmacology
The REDUCE Trial is open access and can be read here. The following comments have been published on the associated JAMA web-page and are shared below: I have submitted the … Continue reading Comments on the REDUCE Trial
The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry: PMCPA … Continue reading Publicly reprimanded
This analysis was published in the BMJ on the 9th July 2024. It has been made open access and can be read in full here. Seven years ago I put … Continue reading Does Frailty need a new name?
This article features in the latest BMJ. It has been made open access and is copied in full below. I campaigned for Scotland to introduce Sunshine legislation. I did so … Continue reading Broken beyond repair